SUNDAY, MARCH 1, 3:30PM
“Impact of a Health-Focused, Direct Fed Microbial (ProVent® ECL) Fed to Weaned Pigs Given a Controlled F18 ETEC Challenge.”
Presented by Joel D. Spencer PhD, Director – Global Research & Innovation, Swine Health & Specialty Products, United Animal Health
Why attend? Postweaning diarrhea caused by F18 Escherichia coli continues to be a major health and economic burden for global swine producers and health teams, contributing to mortality, compromised gut integrity, and performance losses. Increasing antimicrobial resistance further complicates treatment and control strategies. This presentation delivers insights from a controlled research environment designed to isolate treatment effects and support informed decision making. Attendees will walk away with a clearer understanding of how a health focused DFM, ProVent ECL, can fit into broader enteric health and antibiotic reduction strategies.
What You’ll Learn:
- How a health focused, Bacillus based direct fed microbial (ProVent ECL) performed under a controlled F18 ETEC challenge in weaned pigs.
- Key outcomes related to nursery pig mortality, pathogen colonization, and intestinal health following challenge.
- Evidence showing reduced F18 adhesin gene detection on ileal mucosa with higher inclusion of ProVent ECL.
- How dietary strategies may help delay infection and reduce intestinal adhesion of pathogenic E. coli in high pressure health scenarios.
SUNDAY, MARCH 1, 3:45PM
“A Novel Dietary Dairy Bioactive (FXPTM) Enhances Post-Weaning Enteric Health in Nursery Pigs”
Presented by Adrienne Woodward Ph. D., MBA, Sr. Manager – Discovery & Novel Products, United Animal Health
Why attend? Weaned pigs face significant stressors due to environmental and nutritional changes that can compromise gut integrity, immune function, and performance. These challenges are often intensified by enteric pathogens such as rotavirus (RV), enterotoxigenic Escherichia coli (ETEC), Salmonella, and Streptococcus suis, increasing the risk of post weaning diarrhea. Nutrition is critical during this period, yet many solutions address only part of the challenge.
This session will highlight new research on FXP, a novel dietary dairy bioactive containing colostrum derived compounds that support gut health while also exhibiting anti pathogenic activity. Attendees will gain insight into how FXP impacts nursery pig performance and intestinal health, and how its multi mode action may provide broader support than traditional nutritional approaches during the post weaning period.
What You’ll Learn:
- How a novel dietary dairy bioactive (FXP) supports gut integrity and intestinal morphology in nursery pigs during the post weaning challenge period.
- Evidence showing reduced post weaning diarrhea and improved early nursery performance with FXP supplementation.
- How FXP helps mitigate common nursery pathogens including rotavirus, ETEC, Salmonella, and Streptococcus suis.
- Insights into FXP’s multi mode action, combining gut health support with anti pathogenic activity to address post weaning stressors.
SUNDAY, MARCH 1, 12PM – 5PM
MONDAY, MARCH 2, 8AM – 5PM
“In Vitro Evaluation of ProVent ECL, a Bacillus-Based Direct Fed Microbial, Against Pathogenic and Antibiotic-Resistant Swine Escherichia coli.”
Presented by Kaley Pederson Microbiologist III, Microbial Discovery Group
Why Attend? Antimicrobial resistance (AMR) is recognized as one of the top global public health and development threats, affecting human, animal, and environmental sectors. AMR continues to intensify challenges in post weaning
pig health, with highly resistant Escherichia coli contributing to diarrhea, lost performance, and economic impact. Recent U.S. nursery surveillance highlights the widespread presence and diversity of virulence and toxin genes, underscoring the need for more effective management strategies. This poster highlights new in vitro research evaluating ProVent ECL, a health focused Bacillus‐based direct‐fed microbial, shown to inhibit growth of a wide range of pathogenic and highly resistant E. coli isolates from commercial systems. Attendees will gain insight into how ProVent ECL may help reduce pathogen pressure and support nursery health as part of a comprehensive approach to managing post‐weaning challenges.
What You’ll Learn:
- Current surveillance data highlighting the prevalence and genetic complexity of enterotoxigenic E. coli in U.S. nursery pigs.
- Why increasing AMR in post weaning E. coli emphasizes the need for effective mitigation strategies.
- In vitro evidence showing how ProVent ECL inhibits growth across a diverse set of pathogenic and multidrug resistant swine E. coli isolates.
- How these findings build on previous ProVent ECL research evaluating pathogen control and nursery pig health outcomes.